BioStar Capital logo

BioStar Capital

North America, Michigan, United States, Petoskey

Description

BioStar Ventures is a venture capital partnership that focuses on medical device technologies in cardiovascular and orthopaedic medicine.

Investor Profile

BioStar Capital has made 47 investments, with 0 in the past 12 months and 28% as lead.

Stage Focus

  • Series B (38%)
  • Series C (19%)
  • Series D (11%)
  • Series A (11%)
  • Post Ipo Equity (6%)
  • Debt Financing (4%)
  • Series F (4%)
  • Series Unknown (4%)
  • Private Equity (2%)

Country Focus

  • United States (89%)
  • Israel (6%)
  • Italy (4%)

Industry Focus

  • Medical Device
  • Health Care
  • Medical
  • Biotechnology
  • Manufacturing
  • Health Diagnostics
  • Robotics
  • Wellness
  • Therapeutics
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BioStar Capital frequently co-invest with?

Hudson Executive Capital
North America, New York, United States, New York
Co-Investments: 3
Domain Associates
North America, California, United States, San Diego
Co-Investments: 3
Safeguard Scientifics
North America, Pennsylvania, United States, Radnor
Co-Investments: 4
Triventures
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 4
HealthQuest Capital
North America, California, United States, Redwood City
Co-Investments: 3
Essex Woodlands Healthcare Partners
North America, California, United States, Palo Alto
Co-Investments: 3
Edwards Lifesciences
North America, California, United States, Irvine
Co-Investments: 3
Deerfield
North America, New York, United States, New York
Co-Investments: 4
Morgenthaler Ventures
North America, California, United States, Menlo Park
Co-Investments: 3
MF
North America, California, United States, Irvine
Co-Investments: 4

What are some of recent deals done by BioStar Capital?

Nectero Medical

Tempe, Arizona, United States

Nectero Medical develops a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms.

BiotechnologyHealth CareHealth DiagnosticsMedical Device
Series DApr 11, 2024
Amount Raised: $96,000,000
MMI

Pisa, Toscana, Italy

MMI is focused on advancing robotic technology for soft tissue open surgery with the world's smallest wristed instruments.

Health CareMedicalMedical DeviceRobotics
Series CFeb 21, 2024
Amount Raised: $110,000,000
Amplitude Vascular Systems

Ann Arbor, Michigan, United States

Amplitude Vascular Systems is a medical device company focused on safely and effectively treating severely calcified arterial disease.

Health CareMedicalMedical Device
Series BApr 4, 2023
Amount Raised: $8,800,000
Amplitude Vascular Systems

Ann Arbor, Michigan, United States

Amplitude Vascular Systems is a medical device company focused on safely and effectively treating severely calcified arterial disease.

Health CareMedicalMedical Device
Series BJan 5, 2023
Amount Raised: $20,000,000
Amplitude Vascular Systems

Ann Arbor, Michigan, United States

Amplitude Vascular Systems is a medical device company focused on safely and effectively treating severely calcified arterial disease.

Health CareMedicalMedical Device
Series AOct 26, 2022
Amount Raised: $1,240,000
REVA Medical

San Diego, California, United States

REVA Medical develops bioresorbable polymers for vascular applications.

BiotechnologyHealth CareMedicalWellness
Series BAug 9, 2022
Amount Raised: $45,000,000
MMI

Pisa, Toscana, Italy

MMI is focused on advancing robotic technology for soft tissue open surgery with the world's smallest wristed instruments.

Health CareMedicalMedical DeviceRobotics
Series BJul 20, 2022
Amount Raised: $75,000,000
Ablative Solutions

Wakefield, Massachusetts, United States

Ablative Solutions is a medical device firm that offers an alternative to surgical renal denervation for treating hypertension.

BiotechnologyHealth CareMedical Device
Series DJun 13, 2022
Amount Raised: $91,400,000
Foldax

Salt Lake City, Utah, United States

Foldax is engages in synthetic heart valve development to deliver non-thrombogenic aortic and mitral valves at dramatically lower cost.

Developer PlatformManufacturingMedical Device
Series DJun 22, 2020
Amount Raised: $20,000,000
Aria CV

Saint Paul, Minnesota, United States

Aria CV is developing a medical device designed to improve the lives of patients living with the disease of pulmonary hypertension.

Health CareMedical DeviceWellness
Series BFeb 25, 2020
Amount Raised: $31,000,000